Undertaking Decentralized Clinical Trials In The UK ‘Should Not Be A Luxury’

UK needs to do more to address the current uncertainty among sponsors on how decentralized clinical trials can generate regulatory-grade data.

A hiker looking over a sea of clouds in the mountains at dawn.
UK Regulators Must Improve Visibility Around Their Position On Decentralized Trials • Source: Shutterstock

[Editor's Note: This article originally appeared in Pink Sheet, Medtech Insight's sister publication covering pharmaceutical regulation and policy.]

The UK bodies responsible for regulatory and ethics review of clinical trials are being urged to issue clearer guidance on...

More from United Kingdom

More from Europe